XML 37 R13.htm IDEA: XBRL DOCUMENT v3.22.0.1
TDCC Consolidated Statements of Equity Statement - USD ($)
$ in Millions
Total
Common Stock
Add'l Paid-in Capital
Retained Earnings [Member]
Accumulated Other Comprehensive Loss
Unearned ESOP
The Dow Chemical Company
The Dow Chemical Company
Common Stock
The Dow Chemical Company
Add'l Paid-in Capital
The Dow Chemical Company
Retained Earnings [Member]
The Dow Chemical Company
Accumulated Other Comprehensive Loss
The Dow Chemical Company
Unearned ESOP
Dow Inc. [Member]
The Dow Chemical Company
Add'l Paid-in Capital
Dow Inc. [Member]
The Dow Chemical Company
Retained Earnings [Member]
DowDuPont
The Dow Chemical Company
Add'l Paid-in Capital
DowDuPont
The Dow Chemical Company
Retained Earnings [Member]
Beginning balance at Dec. 31, 2018   $ 0 $ 7,042 $ 35,460 $ (9,885) $ (134)   $ 0 $ 7,042 $ 35,460 $ (9,885) $ (134)        
Issuance of parent company stock     28                   $ 65   $ 28  
Stock-based compensation and allocation of ESOP shares     235     45     235     45        
Other     37 14         (37) (14)            
Net income (loss) available for The Dow Chemical Company common stockholder $ (1,359)     (1,359)     $ (1,237)     (1,237)            
Dividends to parent       (535)                   $ (201)   $ (535)
Settlements and transfers related to separation from DowDuPont Inc. 1,935     (14,806) 793   61     (16,009) 793          
Stockholders' Equity, Period Increase (Decrease) | Accounting Standards Update 2014-09       (151)           (151)            
Other comprehensive income (loss) (1,154)       (1,154)           (1,154)          
ESOP shares acquired           (2)           (2)        
Ending balance at Dec. 31, 2019 14,094 8 7,325 17,045 (10,246) (91) 14,862 0 7,333 17,313 (10,246) (91)        
The Dow Chemical Company’s stockholder's equity 13,541           14,309                  
Noncontrolling interests 553           553                  
Issuance of parent company stock     0                   108   0  
Stock-based compensation and allocation of ESOP shares     162     42     162     42        
Other     0 15         0 (15)            
Net income (loss) available for The Dow Chemical Company common stockholder 1,225     1,225     1,235     1,235            
Dividends to parent       0                   (2,233)   0
Settlements and transfers related to separation from DowDuPont Inc. 0     177 0   0     0 0          
Stockholders' Equity, Period Increase (Decrease) | Accounting Standards Update 2014-09       0           0            
Other comprehensive income (loss) (609)       (609)           (609)          
ESOP shares acquired           0           0        
Ending balance at Dec. 31, 2020 13,005 8 7,595 16,361 (10,855) (49) 13,569 $ 0 7,603 16,300 (10,855) (49)        
The Dow Chemical Company’s stockholder's equity 12,435           12,999                  
Noncontrolling interests 570           570                  
Issuance of parent company stock     0                   $ 320   $ 0  
Stock-based compensation and allocation of ESOP shares     236     34     236     34        
Other     0 22         0 (22)            
Net income (loss) available for The Dow Chemical Company common stockholder 6,311     6,311     6,274     6,274            
Dividends to parent       0                   $ (3,264)   $ 0
Settlements and transfers related to separation from DowDuPont Inc. 0     46 0   0     0 0          
Stockholders' Equity, Period Increase (Decrease) | Accounting Standards Update 2014-09       0           0            
Other comprehensive income (loss) 1,878       1,878           1,878          
ESOP shares acquired           0           0        
Ending balance at Dec. 31, 2021 18,739 $ 8 $ 8,151 $ 20,623 $ (8,977) $ (15) 19,029   $ 8,159 $ 19,288 $ (8,977) $ (15)        
The Dow Chemical Company’s stockholder's equity 18,165           18,455                  
Noncontrolling interests $ 574           $ 574